Defining a Model to Predict the Distribution of Topically Applied Growth Factors and Other Solutes in Excisional Full-Thickness Wounds
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 112 (1) , 36-41
- https://doi.org/10.1046/j.1523-1747.1999.00473.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An experimental model to investigate the dynamics of wound contractionBritish Journal of Plastic Surgery, 1995
- Dermal and Underlying Tissue Pharmacokinetics of Lidocaine after topical applicationJournal of Pharmaceutical Sciences, 1994
- Acidic Fibroblast Growth Factor: Evaluation of Topical Formulations in a Diabetic Mouse Wound Healing ModelPharmaceutical Research, 1994
- Subcutaneous Absorption Kinetics and Local Tissue Distribution of Interferon and Other SolutesJournal of Pharmacy and Pharmacology, 1993
- Structure-transport relationships in transdermal iontophoresisAdvanced Drug Delivery Reviews, 1992
- The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure SoresAnnals of Surgery, 1992
- Topical Use of Human Recombinant Epidermal Growth Factor (h‐EGF) in Venous UlcersThe Journal of Dermatologic Surgery and Oncology, 1992
- Assessment of epidermal growth factor in the healing process of clean full-thickness skin woundsAmerican Journal of Obstetrics and Gynecology, 1989
- Transport of β-aminopropionitrile through intact skin or scar tissueJournal of Surgical Research, 1989
- Enhancement of Wound Healing by Topical Treatment with Epidermal Growth FactorNew England Journal of Medicine, 1989